VMP 7322311000001107

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Co-amoxiclav 250mg/62mg/5ml oral suspension
BNF code 0501013K0AAAIAI
Virtual Therapeutic Moiety Co-amoxiclav
Basis of preferred name BAN - British Approved Name
Date of name applicability 18 Nov 2004
Previous name Co-amoxiclav 250mg/62mg oral suspension
Basis of previous name BAN - British Approved Name
Reason for name change Other
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 5.000
Unit dose form units ml
Unit dose unit of measure spoonful
Virtual Product Ingredient
Ingredient Amoxicillin trihydrate
Basis of pharmaceutical strength Based on Base Substance
Basis of strength substance identifier 372687004
Strength value numerator 50.000
Strength value numerator unit mg
Strength value denominator 1.000
Strength value denominator unit ml
Virtual Product Ingredient
Ingredient Potassium clavulanate
Basis of pharmaceutical strength Based on Base Substance
Basis of strength substance identifier 395939008
Strength value numerator 12.500
Strength value numerator unit mg
Strength value denominator 1.000
Strength value denominator unit ml
Ontology Drug Form & Route
Form & Route suspension.oral
Dose Form
Formulation Oral suspension
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Co-amoxiclav 250mg/62mg/5ml oral suspension (Ennogen Healthcare Ltd)
Co-amoxiclav 250mg/62mg/5ml oral suspension (Medihealth (Northern) Ltd)
Co-amoxiclav 250mg/62mg/5ml oral suspension (Sigma Pharmaceuticals Plc)
Virtual Medicinal Product Packs
Co-amoxiclav 250mg/62mg/5ml oral suspension 100 ml

dm+d data retrieved from TRUD: release NHSBSA_4.2.0_20240415000001, imported on 15th April 2024 at 05:09:22.

Feedback